A recent review article by Dutkowski et al. looked at the evolving evidence for machine perfusion in liver transplantation. They explored the evidence and requirements for both HMP and NMP.
They presented the following information:
- That endpoints need to be strictly chosen in order to show evidence of clinical benefits
- AST levels poorly reflect outcomes
- Hospital length of stay is subjective to transplant centers
- The importance of targeting the rescue of damaged organs while ensuring acceptance or rejection of a graft is not dependent on whether it was randomized to MP vs SCS
- The mechanisms of both NMP and HMP are very different
- Due to the in vivo conditions of NMP, the inflammatory responses are activated thus the requirement of strategies to reduce ROS in the system are required
- HMP mitigates the inflammatory response
Overall, they concluded that future investigations should explore more clinically relevant end points and search for the potential protective mechanisms and strategies to evaluate effective repair of the organs prior to transplantation.
Read the full article here: https://doi.org/10.1053/j.gastro.2018.12.037
Check out the most recent posts
July 29, 2022 to August 3, 2022 San Diego, CA Produced by the Transplant Life Foundation, the Transplant Games honor the lasting legacy of donors who gave the ultimate gift of life, highlight the need for and importance of organ, eye, and tissue donation, celebrate...
HMP of Kidneys Compensates for Extended Storage Time: A Single Intervention With a Significant Impact
A study out of Poland by Kruszyna and Richter sought to determine whether with increased cold ischemic times (CIT) and increased use of extended criteria donors (ECD), would hypothermic machine perfusion (HMP) still have the potential to improve outcomes in kidney...
In a multicenter, randomized, controlled trial by Van Rijn, et al, they sought to compare hypothermic oxygenated machine perfusion with static cold storage in liver transplantation from donation after cardiac death (DCD) donors. In this trial, they included 156...
A multicenter retrospective study by de Sandes-Freitas et al. sought to determine the national rate of delayed graft function (DGF) and the associated risk factors with DGF. They studied 8,657 single deceased donor kidney transplants between January 2014 and December...